Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD).

التفاصيل البيبلوغرافية
العنوان:	Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD).
المؤلفون:	van Son KC; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; 26066 Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., van Dijk AM; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; 26066 Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Driessen S; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; 26066 Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Mak AL; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Witjes JJ; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Houttu VAT; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Zwirs D; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Nieuwdorp M; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., van den Born BH; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; Department of Public and Occupational Health, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Fischer JC; Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Tushuizen ME; Department of Gastroenterology and Hepatology, LUMC, Leiden, The Netherlands., Drenth JPH; Department of Gastroenterology and Hepatology, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Hamer HM; Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Beuers UHW; Department of Gastroenterology and Hepatology, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Verheij J; 26066 Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.; Department of Pathology, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands., Holleboom AG; Department of Vascular Medicine, 26066 Amsterdam UMC, Location AMC , Amsterdam, The Netherlands.
المصدر:	Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 May 15. Date of Electronic Publication: 2024 May 15.
Publication Model:	Ahead of Print
نوع المنشور:	Letter
اللغة:	English
بيانات الدورية:	Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE
أسماء مطبوعة:	Original Publication: Berlin ; New York : Walter De Gruyter, c1998-
References:	Younossi, ZM, Golabi, P, Paik, JM, Henry, A, Van Dongen, C, Henry, L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023;77:1335–47. https://doi.org/10.1097/hep.0000000000000004 . (PMID: 10.1097/hep.0000000000000004) van Dijk, AM, Schattenberg, JM, Holleboom, AG, Tushuizen, ME. Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease. United Eur Gastroenterol J 2021;9:903–9. https://doi.org/10.1002/ueg2.12150 . (PMID: 10.1002/ueg2.12150) Lazarus, JV, Anstee, QM, Hagström, H, Cusi, K, Cortez-Pinto, H, Mark, HE, et al.. Defining comprehensive models of care for NAFLD. Nat Rev Gastroenterol Hepatol 2021;18:717–29. https://doi.org/10.1038/s41575-021-00477-7 . (PMID: 10.1038/s41575-021-00477-7) Macpherson, I, Nobes, JH, Dow, E, Furrie, E, Miller, MH, Robinson, EM, et al.. Intelligent liver function testing: working smarter to improve patient outcomes in liver disease. J Appl Lab Med 2020;5:1090–100. https://doi.org/10.1093/jalm/jfaa109 . (PMID: 10.1093/jalm/jfaa109) van Dijk, AM, Vali, Y, Mak, AL, Galenkamp, H, Nieuwdorp, M, van den Born, BJ, et al.. Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: the HELIUS study. Hepatol Commun 2023;7:e2109. https://doi.org/10.1002/hep4.2109 . (PMID: 10.1002/hep4.2109) Troelstra, MA, Witjes, JJ, van Dijk, AM, Mak, AL, Gurney-Champion, O, Runge, JH, et al.. Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: the Amsterdam NAFLD-NASH cohort. J Magn Reson Imag 2021;54:1937–49. https://doi.org/10.1002/jmri.27703 . (PMID: 10.1002/jmri.27703) I. U. enhanced liver fibrosis test (ELF test) . Terrytown, NY: Siemens Healthcare Diagnostics; 2019:1–10 pp. Eddowes, PJ, Sasso, M, Allison, M, Tsochatzis, E, Anstee, QM, Sheridan, D, et al.. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2019;156:1717–30. https://doi.org/10.1053/j.gastro.2019.01.042 . (PMID: 10.1053/j.gastro.2019.01.042) Srivastava, A, Gailer, R, Tanwar, S, Trembling, P, Parkes, J, Rodger, A, et al.. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol 2019;71:371–8. https://doi.org/10.1016/j.jhep.2019.03.033 . (PMID: 10.1016/j.jhep.2019.03.033) Vali, Y, Lee, J, Boursier, J, Spijker, R, Löffler, J, Verheij, J, et al.. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis. J Hepatol 2020;73:252–62. https://doi.org/10.1016/j.jhep.2020.03.036 . (PMID: 10.1016/j.jhep.2020.03.036)
فهرسة مساهمة:	Keywords: advanced liver fibrosis; diagnostic algorithms; enhanced liver fibrosis (ELF)-test; metabolic dysfunction-associated steatotic liver disease (MASLD); reflex testing
تواريخ الأحداث:	Date Created: 20240514 Latest Revision: 20240514
رمز التحديث:	20240515
DOI:	10.1515/cclm-2024-0470
PMID:	38742657
قاعدة البيانات:	MEDLINE

الوصف
تدمد:	1437-4331
DOI:	10.1515/cclm-2024-0470